Thursday, December 21, 2017

T.H. v. Novartis Pharmaceuticals Corporation, S233898


Off-label use: Physicians:



Physicians may, in their professional judgment, prescribe a drug for a purpose other than that for which it has been approved by the FDA. (Buckman Co. v. Plaintiffs’ Leg. Com. (2001) 531 U.S. 341, 351, fn. 5 [“‘Off-label use is widespread in the medical community’”].)



(Cal. S.C., Dec. 21, 2017, T.H. v. Novartis Pharmaceuticals Corporation, S233898).


La prescription "off-label" d'un produit pharmaceutique est admise.

No comments:

Post a Comment